For more information, contact:
Jeff Butler
Public Relations Account Executive
Morton Vardeman & Carlson
770-536-8921
jeff@vardeman.com
Lohmann Animal Health Offers ViBursa CE In Larger Dose Size
WINSLOW, MAINE (Dec. 1, 2008) — Lohmann Animal Health has added an additional dose size for AviPro® ViBursa CE.
The vaccine against infectious bursal disease is now available in 15,000-dose presentations. It is also offered in 2,500 and 10,000 doses.
AviPro® ViBursa CE is a live intermediate vaccine, recommended as an aid in the prevention of infectious bursal disease in chickens. The vaccine is presented in lyophilized form containing a chicken embryo-adapted strain of the ViBursa CE virus. Live vaccines from classic strains will protect against both acute and immunosuppressive forms of infectious bursal disease, caused by any classic IBD strains. AviPro® ViBursa CE can be applied via drinking water, spray or eye drop.
AviPro® ViBursa CE has been successfully used in billions of chickens worldwide to prevent IBD.
Based in Winslow, Maine, LAH is a member of the PHW Group, which comprises 40 companies that produce poultry health products for the global market. For more information, contact LAH at (800) 655-1342 or visit the company's website at www.lahinternational.com.
###
|
